GO-COLITIS Trial in Ulcerative Colitis Patients Shows Simponi Induces Positive Clinical Response
News
Janssen Pharmaceutical’s Simponi (golimumab) induced a clinical response in more than two-thirds of patients with moderate to severe ulcerative colitis in the induction phase of the GO-COLITIS clinical trial, according to the ... Read more